Evidence map›Paper›PMID 41572213›Full record

ArticleBMC medical research methodology2026

Rasch models to assess the impact of lack of measurement invariance and reveal hidden differences in anxiety and depression between groups and over time in patients with early-stage melanoma or breast cancer using the RespOnse Shift ALgorithm at the Item level (ROSALI).

Yseulys Dubuy, Myriam Blanchin, Bastien Perrot, Marianne Bourdon, Véronique Sébille

Registry-linked trialAbstract read
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02893774 (Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02893774 nacompletednot on this map

Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer

TypeinterventionalSponsorInstitut Cancerologie de l'OuestRan2015 to 2023Enrolled314ConditionsBreast Cancer, MelanomaArmsquality of life assessment
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yseulys DubuyNantes Université, Université de Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Nantes, F-44000, France.ORCID http://orcid.org/0000-0001-8390-2285
Myriam BlanchinNantes Université, Université de Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Nantes, F-44000, France.ORCID http://orcid.org/0000-0003-1318-7620
Bastien PerrotNantes Université, Université de Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Nantes, F-44000, France.ORCID http://orcid.org/0000-0002-3701-6693
Marianne BourdonNantes Université, Université de Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Nantes, F-44000, France.
Véronique SébilleNantes Université, Université de Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Nantes, F-44000, France. Veronique.Sebille@univ-nantes.fr.ORCID http://orcid.org/0000-0002-0780-7742

Funding

SIRIC ILIAD INCA-DGOS-Inserm 12558
6 · The paper itself

Abstract

backgroundPatient-reported outcome measures (PROMs) are often challenging to analyze and interpret. Indeed, patients may give different answers to PROMs over time, not only because their level of the target construct (e.g. anxiety) has changed but also because their interpretation of the items aiming at measuring the construct has changed. For instance, cancer treatment may trigger changes in the patients’ internal standard of measurement (i.e., recalibration response shift, RS), resulting in a lack of measurement invariance over time. In addition, interpretation of PROMs items may differ according to cancer type (differential item functioning, DIF). If ignored, DIF and RS may impact inferences made from PROMs; they are also crucial to investigate as they may be related to patients’ adaptation after a salient health event, e.g. cancer diagnosis. Our objectives were to show how cross-sectional and longitudinal Rasch models can be used to detect, interpret, and account for DIF and RS, where appropriate, when measuring anxiety and depression in breast cancer and melanoma patients.

methodsAnxiety and depression were assessed in breast cancer (n = 337) and melanoma patients (n = 110) using the Hospital Anxiety and Depression Scale (HADS) at 1- (T1) and 6-month (T2) post-diagnosis. DIF and RS analyses were performed using the RespOnse Shift ALgorithm at the Item level (ROSALI) based on Rasch models, i.e. cross-sectional and longitudinal Partial Credit Models (PCM).

resultsDIF and RS were identified in the anxiety (DIF and RS) and depression (RS only) subscales of the HADS. DIF and RS had a moderate (anxiety) or significant impact (depression) on the results, providing different conclusions depending on whether or not they were considered. More specifically, wrongly presuming (longitudinal) measurement invariance would have resulted in overestimating the increase in depression over time among breast cancer patients.

conclusionThe ROSALI procedure based on Rasch models is freely available ( https://pro-online.net/ ). ROSALI enabled to investigate measurement invariance at item-level, providing insight into cancer patients’ experience, possibly revealing psychological distress but also psychological adaptation to challenging health events. Although some methods are available, DIF and RS are still too often ignored which can lead biased measurements of constructs and to suboptimal healthcare decision making. TRIAL REGISTRATION NUMBER: n°CT.gov: NCT02893774, registration date: 2016-08-25. Of note, this was a prospective study which was retrospectively registered.

Indexed as

AlgorithmsAnxietyBreast NeoplasmsDepressionMelanomaPatient Reported Outcome MeasuresPsychometricsAdultAgedCross-Sectional StudiesFemaleHumansLongitudinal StudiesMiddle AgedSurveys and QuestionnairesAnxietyBreast cancerDepressionDifferential item functioningMelanomaResponse shift

Identifiers

PMID41572213
PMCPMC12961859

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.